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HSPA12A attenuates lipopolysaccharide-induced liver injury
through inhibiting caspase-11-mediated hepatocyte pyroptosis
via PGC-1α-dependent acyloxyacyl hydrolase expression
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Abstract
Liver dysfunction is strongly associated with poor survival of sepsis patients. Cytosolic lipopolysaccharide (LPS) sensing by
Caspase-4/5/11 for pyroptosis activation is a major driver of the development of sepsis. Studies in macrophages and
endothelial cells have demonstrated that LPS is inactivated by acyloxyacyl hydrolase (AOAH) and leading to desensitizing
Caspase-4/5/11 to LPS. However, little is known about the cytosolic LPS-induced pyroptosis in hepatocytes during sepsis.
Heat shock protein 12A (HSPA12A) is a novel member of the HSP70 family. Here, we report that LPS increased HSPA12A
nuclear translocation in hepatocytes, while knockout of HSPA12A (Hspa12a−/−) in mice promoted LPS-induced acute liver
injury. We also noticed that the LPS-induced Caspase-11 activation and its cleavage of gasdermin D (GSDMD) to produce
the membrane pore-forming GSDMDNterm (markers of pyroptosis) were greater in livers of Hspa12a−/− mice compared with
its wild type controls. Loss- and gain-of-function studies showed that HSPA12A deﬁciency promoted, whereas HSPA12A
overexpression inhibited, cytosolic LPS accumulation, Caspase-11 activation and GSDMDNterm generation in primary
hepatocytes following LPS incubation. Notably, LPS-induced AOAH expression was suppressed by HSPA12A deﬁciency,
whereas AOAH overexpression reversed the HSPA12A deﬁciency-induced promotion of LPS-evoked and Caspase-11mediated pyroptosis of hepatocytes. In-depth molecular analysis showed that HSPA12A interacted directly with peroxisome
proliferator-activated receptor γ coactivator 1α (PGC-1α) and increased its nuclear translocation, thereby inducing AOAH
expression for cytosolic LPS inactivation, which ultimately leading to inhibition of the Caspase-11 mediated pyroptosis of
hepatocytes. Taken together, these ﬁndings revealed HSPA12A as a novel player against LPS-induced liver injury by
inhibiting cytosolic LPS-induced hepatocyte pyroptosis via PGC-1α-mediated AOAH expression. Therefore, targeting
hepatocyte HSPA12A represents a viable strategy for the management of liver injury in sepsis patients.
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Sepsis, a leading cause of death in intensive care units, is
characterized by life-threatening organ dysfunction caused
by a dysregulation of the host response to infection [1].
A number of organs are ultimately affected, but liver
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dysfunction develops early during sepsis, often on the day
of diagnosis [2]. Because the liver plays important roles in
the maintenance of metabolic and immune homeostasis,
liver injury is strongly associated with poor outcome of
sepsis patients. However, there is no speciﬁc therapy for
this condition, which implies that a more comprehensive
understanding of the pathogenesis of sepsis-induced liver
injury is required.
A study from Intensive Care Over Nations showed that
Gram-negative bacterial infections were more common than
Gram-positive bacterial infections among patients with
sepsis in the USA [3]. In response to infection, the multiple
pathways are activated when highly conserved microbial
pathogen-associated molecular patterns are recognized by
pattern- recognition receptors. Lipopolysaccharide (LPS) is
a major component of the outer membrane of Gramnegative bacteria and plays a critical role in sepsis by overactivating the innate immune system [4]. Extracellular LPS
was thought to induce sepsis exclusively via the secretion of
proinﬂammatory cytokines by binding to cell-surface tolllike receptor 4 (TLR4) [4]. However, the disappointing
results of TLR4 inhibitors as anti-sepsis drugs in clinical
trials indicate that a more important, TLR4-independent
mechanism for LPS-induced injury may exist. Indeed,
recent studies have shown that cytosolic LPS is a major
driver of sepsis development and organ dysfunction without
TLR4 requirement [4–6]. Therefore, promoting LPS turnover once endotoxin is delivered to the cytosol will
diminish the LPS-induced septic injury. Cytosolic LPS is
sensed by its intracellular receptors, Caspase-11 in rodents
and Caspase-4/5 in humans, leading to their activation.
Activated Caspase-4/5/11 cleaves gasdermin D (GSDMD)
to generate an N-terminal fragment (GSDMDNterm), which
oligomerizes to form pores in the cytoplasmic membrane
for the secretion of inﬂammatory mediators and ultimately
causing regulated cell death, which is termed as pyroptosis
[4, 5, 7, 8]. Thus, cleaved Caspase-11 and cleaved gasdermin D were considered as markers of pyroptosis. Therefore,
desensitizing of cytosolic LPS by Caspase-4/5/11 has been
proposed to be a potential therapeutic target for sepsis
development [4].
The sensing of intracellular LPS by Caspase-4/5/11 has
been shown to be determined by the six acyl chains in lipid
A-moiety of intact LPS. Bexakis-acylated LPS fully activates, penta-acylated LPS weakly activates, and tetraacylated LPS does not activate Caspase-11 [4, 9]. Intriguingly, the secondary (acyloxyacyl-linked) fatty acids of LPS
can be removed by acyloxyacyl hydrolase (AOAH), a host
enzyme, and leading to LPS biologically inactivated and
unable to be sensed by Caspase-4/5/11 [10, 11]. Indeed,
studies conducted in endothelial cells and macrophages
have shown that AOAH deﬁciency exacerbated LPSinduced lung injury, whereas appropriate AOAH activity
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is associated with effective host defense against bacterial
LPS [12, 13]. However, little is known regarding the role of
AOAH in sepsis-induced hepatocyte injury or the regulation
of AOAH expression.
Heat shock protein A12A (HSPA12A) is an atypical
member of the heat shock protein 70 family [14]. We have
recently demonstrated that HSPA12A is required for cerebral protection and obesity development [15, 16], and in
particular, that HSPA12A is involved in the development of
high-fat diet-induced non-alcoholic fatty liver disease [17],
suggesting that it plays a role in the regulation of hepatic
homeostasis. However, the role of HSPA12A in sepsisinduced organ injury, including liver dysfunction, has not
been established.
Here, we report that HSPA12A protein translocated to
the nucleus of hepatocytes following LPS treatment, while
knockout of HSPA12A (Hspa12a−/−) in mice exacerbated
LPS-induced acute liver injury. Further molecular analysis
showed that the hepatoprotection of HSPA12A was mediated by inhibiting cytosolic LPS-induced pyroptosis of
hepatocytes via peroxisome proliferator-activated receptor γ
coactivator 1α (PGC-1α)-mediated AOAH expression.

Results
HSPA12A demonstrates nuclear translocation in
hepatocytes following exposure to LPS
To evaluate the possible involvement of HSPA12A in sepsisinduced liver injury, we measured HSPA12A expression in
the livers of mice following LPS challenge. The dose-effect
of LPS on hepatic HSPA12A protein abundance was
examined by challenge with LPS at dosages of 2.5, 5, 10,
and 20 mg/kg for 6 h. HSPA12A protein levels were signiﬁcantly lower in the cytosolic but higher in the nuclear
fractions of mouse livers following challenge with LPS at
dosages of 5, 10, and 20 mg/kg, respectively, than those of
the normal saline (NS)-treated control mice (Figs. 1a, S1a).
We therefore selected 5 mg/kg of LPS to challenge mice for
different durations (3, 6, 12, and 24 h), and found that
HSPA12A protein levels were rapidly decreased in the
cytosolic but increased in the nuclear fractions after challenge with LPS for 6 h, respectively, when compared with
those of the NS controls (Figs. 1a, S1b).
To determine whether these changes of HSPA12A
occurred in liver hepatocytes, HSPA12A expression was
measured in primary hepatocyte cultures following incubation with LPS for 6 h at different dosages (250, 500,
1000, and 2000 ng/ml). Similarly to the in vivo ﬁndings,
incubation with LPS reduced the abundance of HSPA12A
in the cytosolic but increased it in the nuclear fractions of
the primary hepatocytes and peaked at 500 ng/ml of dosage
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Fig. 1 HSPA12A deﬁciency promoted the LPS-induced hepatic
injury. a HSPA12A protein expression in livers. Cytosolic and
nuclear protein fractions were prepared from mice livers following
treatment with LPS or normal saline (NS) for 6 h. HSPA12A
expression was analyzed by immunoblotting analysis. Blots for
GAPDH or Lamin A/C served as loading controls. Data are mean ±
SD, **P < 0.01 by Student’s two-tailed unpaired t test. n = 6/group. b
HSPA12A protein expression in primary hepatocytes. Cytosolic and
nuclear protein fractions were prepared from primary hepatocytes
following incubation with LPS or NS for 6 h. HSPA12A expression
was analyzed by immunoblotting analysis. Blots for GAPDH or Lamin
A/C served as loading controls. Data are mean ± SD, **P < 0.01 by
Student’s two-tailed unpaired t test. n = 6/group. c HSPA12A

expression in Hspa12a−/− mice. HSPA12A expression was examined
in mice livers and isolated primary hepatocytes using immunoblotting.
Note that HSPA12A expression was absent in livers and hepatocytes
of Hspa12a−/− mice. n = 10 mice/group. WT, wild type; Hspa12a−/−,
HSPA12A knockout. d ALT and AST activities in mouse serum. Mice
were treated with LPS or NS for 6 h. Serum was collected for ALT and
AST activity measurements. Data are mean ± SD, *P < 0.05 and **P <
0.01 by two-way ANOVA followed by Tukey’s test. n = 6 for each
NS group and n = 10 for each LPS group. e ALT and AST activities in
culture medium. Primary hepatocytes were incubated with LPS or NS
for 6 h. Culture medium was collected for ALT and AST activity
measurements. Data are mean ± SD, *P < 0.05 and **P < 0.01 by twoway ANOVA followed by Tukey’s test. n = 5/group.

(Figs. 1b, S1c). We thus selected 500 ng/ml LPS to challenge primary hepatocytes for different durations (3, 6, 12,
and 24 h), and found that HSPA12A protein levels were
lower in the cytosolic but higher in the nuclear fractions
after LPS challenge and peaked at 6 h, respectively, when
compared with those of the NS controls (Figs. 1b, S1d).

Hepatocytes Hspa12a mRNA expression was not affected
by LPS treatment (Fig. S2). These data show that hepatocyte HSPA12A undergoes nuclear translocation following
LPS exposure.
Based on these ﬁndings, we selected 5 mg/kg LPS to
treat mice and 500 ng/ml LPS to treat primary hepatocytes
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for 6 h in the following experiments. Mice treated with LPS
(5 mg/kg) for 6 h exhibited reduction of body temperature
and animal activity, decrease of systolic blood pressure,
decreases of arterial blood oxygen saturation (SO2) and
partial pressure of blood oxygen (pO2) whereas increased
partial pressure of blood carbon dioxide pressure (pCO2),
and increase of urea-nitrogen (Urea) (Fig. S3a–e) These
changes suggest that mice treated with LPS (5 mg/kg) for
6 h undergoes a septic shock response. No mice died during
experiments (Fig. S3f). Moreover, the liver injury, which
indicated by increases of alanine transaminase (ALT)
and aspartate transaminase (AST) activities in serum and
activation of Caspase-11 in livers, were also signiﬁcantly
increased following treatment with LPS at 5 mg/kg of
dosage for 6 h (Fig. S4a–d). Also, ALT and AST activities
in culture medium and Caspase-11 activation in hepatocytes
were signiﬁcantly increased in primary hepatocyte
cultures following incubation with 500 ng/ml LPS for 6 h
(Fig. S5a–d).

HSPA12A deﬁciency promotes LPS-induced injury in
both mouse liver and primary hepatocytes
We next determined whether HSPA12A is required for the
development of LPS-induced liver injury using Hspa12a−/−
mice, in which HSPA12A expression is absent in the liver
and the derived primary hepatocytes (Fig. 1c). To evoke
LPS-induced sepsis, mice were administrated with LPS for
6 h. LPS increased ALT and AST activities in the serum of
mice of both genotypes versus their respective NS-treated
controls (Fig. 1d). However, the LPS-induced increases in
serum ALT and AST activities were greater in Hspa12a−/−
mice than in WT controls. When LPS challenge up to 24 h,
Hspa12a−/− mice still demonstrated higher serum ALT and
AST activities than WT mice (Fig. S6). We also found that
Hspa12a−/− mice demonstrated lower body temperature
and activities than those in WT mice following LPS treatment (Fig. S7).
To determine whether the exacerbated liver injury in
Hspa12a−/− mice is directly attributable to hepatocyte
damage, we isolated primary hepatocytes from Hspa12a−/−
and WT mice (Fig. 1c, right panels). Following LPS
exposure for 6 h, increases in ALT and AST activities were
detected in cell culture medium of both genotypes (Fig. 1e).
However, the LPS-induced increases in ALT and AST
activities were larger in the medium of Hspa12a−/− hepatocytes than in WT controls, suggesting that HSPA12A
deﬁciency exacerbated the LPS-induced ALT and AST
leakage from hepatocytes. Taken together, these data indicate that HSPA12A is required for hepatoprotection against
LPS challenge.
To investigate whether the exacerbated hepatic injury
in Hspa12a−/− mice is a primary event, we examined
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injuries in other organs according to previous studies
[18, 19]. Arterial blood gas analysis showed that LPS
signiﬁcantly decreased pO2 and SO2 in both genotypes
(Fig. S8a). The pCO2 was remained unchanged in WT
mice but increased in Hspa12a−/− mice following LPS
challenge. Though Hspa12a−/− mice showed trends of
decrease in pO2 and SO2 and increase in pCO2 compared
with WT mice, the differences did not reached a statistical
signiﬁcance. LPS increased blood Urea levels in both
genotypes; however, no difference of Urea levels was
detected between WT and Hspa12a−/− mice following
LPS treatment (Fig. S8b). Histological examination of
spleen showed that LPS caused hyperemia, increased
leukocyte inﬁltration in the red pulp, and increased percentage of white pulp in both genotypes; however, the
LPS-induced histological abnormalities were comparable
between WT and Hspa12a−/− mice (Fig. S8c). LPS also
caused histological abnormalities in intestines, like an
increase in leukocyte inﬁltration in lamina propria and a
decrease in ﬁnger-like villus projection in both genotypes;
however, the LPS-induced abnormalities were comparable
between genotypes (Fig. S8d).

HSPA12A deﬁciency increases LPS accumulation in
hepatocytes
Cytosolic LPS has been proposed to be a major initiator of
cell damage during sepsis/septic shock [4, 5, 20]. Because
the liver is the principal organ responsible for clearing circulating LPS and hypotacyte import a substantial quantity
of LPS [21–23], we determined the effect of HSPA12A
deﬁciency on LPS deposition in the liver in vivo and primary hepatocytes in vitro. Following administration of
FITC-conjugated LPS (FITC-LPS) for 6 h, Hspa12a−/−
mice had higher serum and liver LPS contents than WT
mice (Figs. 2a, S9). Furthermore, immunostaining demonstrated the presence of FITC-LPS in AFP-positive cells in
livers of mice of both genotypes, but to a greater contents in
Hspa12a−/− livers, suggesting that HSPA12A deﬁciency
exacerbated the accumulation of LPS in mouse hepatocytes
(Fig. 2b). Consistent with this ﬁnding, the in vitro experiments demonstrated greater intracellular accumulation of
LPS in Hspa12a−/− primary hepatocytes than in WT control
following incubation with FITC-LPS for 6 h (Fig. 2c), and
the accumulation showed a time-dependent manner
(Fig. S10). To determine whether intracellular LPS was
free in cytosol or within intracellular vesicles, we
performed immunostaining for an intracellular vesicle
marker Flotillin-1 according to previous studies [24]. We
found that predominant FITC-LPS was not within intracellular vesicles (Fig. S11). Collectively, these data suggest
that HSPA12A deﬁciency increases intra-hepatocyte LPS
accumulation following LPS exposure.

HSPA12A attenuates lipopolysaccharide-induced liver injury through inhibiting caspase-11-mediated. . .
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Fig. 2 HSPA12A deﬁciency increased intra-hepatocyte LPS
abundance following LPS exposure. a LPS contents in liver homogenates. 6 h after FITC-LPS treatment, liver tissues were collected
from mice. LPS abundance in liver homogenates (unites/mg tissue,
relative) was indicated by the FITC ﬂuorescence intensity that measured by a ﬂuorometer at excitation/emission wavelengths of 490/
530 nm. Data are mean ± SD, *P < 0.05 by Student’s two-tailed
unpaired t test. n = 5/group. b LPS in cytoplasm of hepatocytes of
mouse livers. Frozen liver sections were prepared 6 h after FITC-LPS
treatment. The sections were immunostained with alpha-fetoprotein

(AFP), and Hoechst33342 was used to counter stain nuclei. Note that
more FITC-LPS was present in hepatocyte cytoplasm of Hspa12a−/−
mouse livers. Scale bar = 20 μm. n = 4/group. c LPS in cytoplasm of
primary hepatocytes. After incubation with FITC-LPS for 6 h, the
primary hepatocytes were counter stained with Hoechst33342. The
staining was observed and quantiﬁed using a ﬂuorescence microscope.
Data were expressed as FITC ﬂuorescence intensity *103/mm2 cell
area. Data are mean ± SD, **P < 0.01 by Student’s two-tailed unpaired
t test. n = 3/group. Scale bar = 20 μm.

HSPA12A deﬁciency promotes hepatocyte
pyroptosis following LPS challenge

(markers of pyroptosis) following LPS treatment (Fig. 3b).
However, the LPS-induced Caspase-11 activation and
GSDMDNterm peptide generation were more marked in
Hspa12a−/− livers than in WT livers (Fig. 3b).
LPS has been shown to induce pyroptosis in endothelial
cells, macrophages, and splenic cells [5, 8, 25]; however, little
is known about this process in hepatocytes. To determine
whether hepatocytes respond to cytoplasmic LPS for initiating
Caspase-11-mediated pyroptosis and whether HSPA12A
inﬂuences this process, we performed experiments in primary
hepatocytes. We found that the LPS-induced upregulation of
Caspase-11 mRNA was greater in Hspa12a−/− than WT
hepatocytes (Fig. 3a, right panel). Similarly, the LPS-induced
Caspase-11 activation and GSDMDNterm peptide production

Because cytosolic LPS can be sensed by its intracellular
receptor Caspase-11, which induces pyroptosis in mice
[5, 8, 25], we next determined the effects of HSPA12A
deﬁciency on Caspase-11-mediated pyroptosis in the liver. We
found that LPS upregulated Caspase-11 mRNA expression in
the livers of mice of both genotypes, but this LPS-induced
upregulation was more marked in livers of Hspa12a−/− mice
than in those from WT controls (Fig. 3a, left panel). At the
protein levels, mouse livers of both genotypes showed greater
Caspase-11 activation and its cleavage of GSDMD to produce
the active membrane pore-forming GSDMDNterm peptide
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Fig. 3 HSPA12A deﬁciency promoted Casnpase-11-mediated
pyroptosis in both mouse livers in vivo and primary hepatocytes
in vitro. a Liver tissues were collected from mice 6 h after LPS or
normal saline (NS) treatment. In another set of experiments, cultured
primary hepatocytes were collected after LPS or NS incubation for 6 h.
The following analysises were performed. Caspase-11 mRNA
expression was evaluated using real-time PCR. Data are mean ± SD,

*P < 0.05 and **P < 0.01 by two-way ANOVA followed by Tukey’s
test. n = 6–10/group. Caspase-11 activation and GSDMD cleavage
was examined in livers (b) and primary hepatocytes (c) using immunoblotting. Blots for GAPDH served as loading controls. Data are
mean ± SD, *P < 0.05 and **P < 0.01 by two-way ANOVA followed
by Tukey’s test. n = 6/group.

(markers of pyroptosis) was more marked in HSPA12Adeﬁcient hepatocytes (Fig. 3c). The exacerbation of LPSinduced pyroptosis in Hspa12a−/− hepatocytes was conﬁrmed
by the increase of lactic acid dehydrogenase (LDH) leakage
compared withWT controls (Fig. S12). Taken together, these
data suggest that HSPA12A is required for the inhibition of
cytosolic LPS-induced pyroptosis in hepatocytes.

To investigate whether the cytosolic LPS accumulation is
Caspase-11 dependent, we examined whether knockdown
of Caspase-11 could impact LPS accumulation in hepatocytes. Knockdown of Caspase-11 by siRNA did not change
the cytosolic FITC-LPS abundance in both WT and
Hspa12a−/− hepatocytes, respectively, compared with their
scramble controls (Fig. S13a, b).

HSPA12A attenuates lipopolysaccharide-induced liver injury through inhibiting caspase-11-mediated. . .
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Fig. 4 HSPA12A deﬁciency promoted the LPS-induced inﬂammatory response. Liver tissues were collected from mice 6 h after
LPS or normal saline (NS) treatment. Also, cultured primary hepatocytes were collected after LPS incubation for 6 h. The following
analysises were performed. a Inﬂammatory foci. H&E staining was
performed on parafﬁn-embedded section of mouse livers. Inﬂammatory foci were observed and quantiﬁed using a microscope. Data are
mean ± SD, **P < 0.01 by two-way ANOVA followed by Tukey’s
test. n = 3/NS group and n = 6/LPS group. Scale bar = 100 μm (upper
panels) and 50 μm (down panels). b Macrophage and neutrophil

recruitments. Immunostaining for F4/80 (macrophage) and neutrophils
was performed on frozen sections of mouse livers. Hoechst 33342 was
counter stained to visualize nuclei. The staining was observed and
quantiﬁed using a ﬂuorescence microscope. Data are mean ± SD, **P
< 0.01 by two-way ANOVA followed by Tukey’s test. n = 3/group.
Scale bar = 50 μm. c Expression of mRNA levels. Levels of the
indicated mRNA expression in livers (left panel) and primary hepatocytes (right panel) were evaluated using real-time PCR. Data are
mean ± SD, *P < 0.05 and **P < 0.01 by Student’s two-tailed unpaired
t test. n = 4–11/group.

HSPA12A deﬁciency exacerbates LPS-induced
hepatic inﬂammation

recruitment of macrophages (F4/80+) and neutrophils
was more pronounced in Hspa12a−/− livers than WT
livers (Fig. 4b). In agreement with this, Hspa12a−/− livers
showed higher mRNA expression of proinﬂammatory
mediators, including Nlrp1, Nlrp3, Casp1, Asc, Tnfa, and
Il8, than WT livers following LPS challenge (Fig. 4c, left
panel). Similar results were obtained in primary hepatocyte cultures, which showed higher mRNA levels of
Nlrp1, Asc, Tnfa, and Il8 in Hspa12a−/− hepatocytes than

Previous studies have demonstrated that pyroptosis causes
inﬂammatory damage [5, 26, 27]. As shown in Fig. 4a,
LPS administration increased the number of inﬂammatory
foci in the livers of both genotypes, but there were still
more inﬂammatory foci in Hspa12a−/− livers than in WT
livers. In addition, we found that the LPS-induced
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in WT hepatocytes after LPS incubation (Fig. 4c, right
panel).

HSPA12A deﬁciency reduces the expression of
AOAH, a lipase responsible for the inactivation of
cytosolic LPS
To determine how HSPA12A deﬁciency increases cytosolic
LPS accumulation and exacerbates hepatocyte pyroptosis, we
measured AOAH expression in mouse livers because AOAH
is a lipase responsible for the inactivation of LPS [10, 11].
Following LPS challenge, Aoah mRNA expression increased
in WT livers but remained unchanged in Hspa12a−/− livers
when compared with their respective NS controls (Fig. 5a). In
line with it, AOAH protein expression increased in WT livers
but remained unchanged in Hspa12a−/− livers when compared with their respective NS controls following LPS challenge (Fig. 5b).
Next, we determined whether HSPA12A deﬁciency in
hepatocytes results in a reduction in AOAH expression. We
found that the LPS-induced increase of Aoah mRNA
expression was attenuated in Hspa12a−/− hepatocytes
compared with WT hepatocytes (Fig. 5c). Furthermore,
AOAH protein expression was higher in WT hepatocytes,
but remained unchanged in Hspa12a−/− hepatocytes following LPS exposure, when compared with their respective
NS controls (Fig. 5d). Notably, both immunoblotting and
immunoﬂuorescence demonstrated a lower AOAH protein
content in Hspa12a−/− hepatocytes than in WT hepatocytes
in the presence of LPS (Fig. 5d, e). The data indicates that
LPS was not as efﬁciently de-activated in the absence of
HSPA12A.

Overexpression of HSPA12A upregulates AOAH
expression, reduces cytosolic LPS content, and
inhibits pyroptosis in primary hepatocytes following
LPS incubation
Next, we determined whether overexpression of HSPA12A
would ameliorate LPS-induced hepatocyte injury. To this end,
HSPA12A was overexpressed (Hspa12ao/e) in WT primary
hepatocytes by infection with Hspa12a-adenovirus, and cells
infected with empty adenovirus served as negative controls
(NC), as previously described [17] (Fig. 6a). In the presence
of LPS, Hspa12ao/e hepatocytes showed higher Aoah mRNA
expression than NC controls (Fig. S14). Furthermore, the
LPS-induced upregulation of AOAH protein was more
marked in Hspa12ao/e hepatocytes than NC controls (Fig. 6b).
In addition, immunoﬂuorescence showed greater AOAH
protein abundance in Hspa12ao/e hepatocytes than in NC cells
following incubation with LPS (Fig. 6c).
Consistent with the upregulation of AOAH, less cytosolic LPS was present within Hspa12ao/e primary
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hepatocytes than in NC cells following FITC-LPS incubation (Fig. 6d), suggesting that HSPA12A may inhibit the
cytosolic LPS-induced pyroptosis of hepatocytes. Indeed,
the LPS-induced Caspase-11 activation and GSDMDNterm
peptide generation were attenuated in Hspa12ao/e hepatocytes compared with NC cells (Fig. 6e). Accordingly, the
LPS-induced ALT and AST leakage from primary hepatocytes was also attenuated by HSPA12A overexpression
(Fig. 6f).

The hepatoprotective effect of HSPA12A is
mediated via upregulation of AOAH
To determine whether the protection of HSPA12A against
LPS-induced pyroptosis is mediated through upregulation
of AOAH, we performed loss- and gain- of AOAH function
experiments in primary hepatocytes. We ﬁrst determined
whether AOAH overexpression would rescue the promoted
pyroptosis by HSPA12A deﬁciency. To this end, AOAH
was overexpressed in WT and Hspa12a−/− primary hepatocytes by infection with Aoah-adenovirus, and the hepatocytes infected with empty adenovirus served as NC
controls (Figs. 7a, S15). We found that AOAH overexpression prevented the HSPA12A deﬁciency-induced
increases in Caspase-11 activation and GSDMDNterm generation following LPS incubation (Fig. 7b). In addition,
AOAH overexpression prevented the HSPA12A deﬁciencyinduced increases in ALT and AST leakage from LPStreated primary hepatocytes (Fig. 7c). In striking contrast,
knockdown of AOAH in Hspa12ao/e primary hepatocytes,
which was achieved by transfection with Aoah-targeting
siRNA (Fig. 7d), increased ALT and AST leakage from
hepatocytes compared with that from scrambled siRNAtransfected Hspa12ao/e hepatocytes following LPS exposure
(Fig. 7e). Taken together, these ﬁndings suggest that the
HSPA12A-induced protection against LPS-induced hepatocyte pyroptosis is via the upregulation of AOAH.

HSPA12A upregulates AOAH expression through an
interaction with PGC-1α
Finally, we sought to answer the question about how
HSPA12A regulates AOAH expression. Because
HSPA12A demonstrated nuclear translocation following
LPS exposure (Fig. 1b), we hypothesized that it may bind
and promote the nuclear translocation of certain transcription factors or transcriptional coactivators that are required
for Aoah gene expression. Gene promoter analysis (http://
gene-regulation.com) showed the presence of putative
binding sites of CCAAT/enhancer-binding protein alpha
(C/EBPα) and peroxisome proliferator- activated receptor
gamma (PPARγ), two transcription factors, within the Aoah
promoter. Indeed, we observed a higher abundance of
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Fig. 5 HSPA12A deﬁciency suppressed AOAH expression in both
mouse livers in vivo and primary hepatocytes in vitro. Liver tissues
were collected from mice 6 h after LPS or normal saline (NS) treatment. In another set of experiments, cultured primary hepatocytes were
collected after LPS or NS incubation for 6 h. The following analysises
were performed. a Liver Aoah mRNA expression was evaluated using
real-time PCR. Data are mean ± SD, *P < 0.05 and ** P < 0.01 by twoway ANOVA followed by Tukey’s test. n = 6/NS group and n = 11/
LPS group. b Liver AOAH protein expression was evaluated using
immunoblotting. Data are mean ± SD, **P < 0.01 by two-way
ANOVA followed by Tukey’s test. n = 6 /group. c Primary

hepatocyte Aoah mRNA expression was evaluated using real-time
PCR. Data are mean ± SD, *P < 0.05 and **P < 0.01 by two-way
ANOVA followed by Tukey’s test. n = 6/NS group and n = 5/LPS
group. d Primary hepatocyte AOAH protein expression was evaluated
using immunoblotting. Data are mean ± SD, *P < 0.05 and **P < 0.01
by two-way ANOVA followed by Tukey’s test. n = 6/group. e AOAH
protein was immunostained in primary hepatocytes. Hoechst 33342
was used to counter stain nuclei. Data was expressed as ﬂuorescence
intensity/cell. Scale bar = 20 μm. Data are mean ± SD, **P < 0.01 by
Student’s two-tailed unpaired t test. n = 3/group.

C/EBPα and PPARγ proteins in the nuclear fractions of
Hspa12ao/e primary hepatocytes following LPS incubation
(Fig. 8a). However, immunoprecipitation-immunoblotting
analysis revealed that neither C/EBPα nor PPARγ proteins

could be recovered from ﬂag-tagged HSPA12A immunocomplexes prepared from LPS-treated primary hepatocytes
(Fig. 8b), suggest no direct interaction of HSPA12A with
C/EBPα or PPARγ.
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Fig. 6 Overexpression of HSPA12A upregulated AOAH expression, reduced cytosolic LPS content, inhibited Caspase-11mediated pyroptosis in primary hepatocytes upon LPS incubation. WT primary hepatocytes were infected with Hspa12a-adenovitus
to overexpress HSPA12A (Hspa12ao/e). WT hepatocytes infected
empty virus served as negative controls (NC). After incubation with
LPS (or FITC-LPS) or normal saline (NS) for 6 h, the following
analysises were performed. a Expression of HSPA12A was examined
by immunoblotting. Data are mean ± SD, **P < 0.01 by Student’s twotailed unpaired t test. n = 6/group. Endogenous HSPA12A was 75
kDa, whereas Exogenous HSPA12A was 78 kDa due to containing 3
ﬂags. b AOAH expression was evaluated using immunoblotting. Data
are mean ± SD, **P < 0.01 by two-way ANOVA followed by Tukey’s
test. n = 6/group. c AOAH immunoﬂuorescence was examined in
LPS-incubated primary hepatocytes. Hoechst 33342 was used to
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counter stain nuclei. Data were expressed as ﬂuorescence intensity/
cell. Scale bar = 20 μm. Data are mean ± SD, **P < 0.01 by Student’s
two-tailed unpaired t test. n = 3/group. d After incubation with FITCLPS for 6 h, the primary hepatocytes were counter stained with
Hoechst 33342. The stained ﬂuorescence was observed and quantiﬁed
using a ﬂuorescence microscope. Data were expressed as FITC
ﬂuorescence intensity *103/mm2 cell area. Scale bar = 20 μm. Data are
mean ± SD, **P < 0.01 by Student’s two-tailed unpaired t test. n = 3/
group. e Caspase-11 activation and GSDMD cleavage was examined
using immunoblotting. Blots for GAPDH served as loading controls.
Data are mean ± SD, **P < 0.01 by two-way ANOVA followed by
Tukey’s test. n = 6/group. f ALT and AST activities in culture medium
were analyzed. Data are mean ± SD, *P < 0.05 and **P < 0.01 by twoway ANOVA followed by Tukey’s test. n = 4/ALT group and n = 6/
AST group.
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Fig. 7 The hepatic protection of HSPA12A was mediated via
upregulation of AOAH. Overexpression of AOAH reversed the promotion effect of HSPA12A deﬁciency in LPS-induced hepatocyte
damage. WT and Hspa12a−/− primary hepatocytes were infected with
Hspa12a-adenovitus to overexpress AOAH (Aoaho/e), and Hspa12a−/−
hepatocytes infected empty virus served as negative controls (NC).
Upon LPS incubation for 6 h, AOAH expression (a), Caspase-11
activation and GSDMD cleavage (b) were examined using immunoblotting. The activities of ALT and AST in culture medium were also
measured (c). Data are mean ± SD, *P < 0.05 and **P < 0.01 by two-

way ANOVA followed by Tukey’s test. n = 6/group. Knockdown of
AOAH promoted hepatocyte injury in Hspa12ao/e primary hepatocytes
upon LPS incubation. AOAH was knockdown in Hspa12ao/e primary
hepatocytes by siRNA, and Scramble RNA-transfected Hspa12ao/e
hepatocytes cells served as controls. Upon LPS incubation for 6 h,
AOAH expression was examined in cells using immunoblotting (d) and
ALT and AST activities in culture medium were also measured (e).
Data are mean ± SD, *P < 0.05 and **P < 0.01 by Student’s two-tailed
unpaired t test. n = 6/group.

Unexpectedly, PGC-1α of 113 kDa in size, but not of 38
kDa, was recovered from the ﬂag-tagged HSPA12A immunocomplexes from LPS-incubated primary hepatocytes
(Fig. 8b). Interestingly, the PGC-1α protein levels in nuclear
fractions of primary hepatocytes were increased by HSPA12A
overexpression but decreased in HSPA12A deﬁciency in the

presence of LPS (Fig. 8c). Consistent with this, Hspa12ao/e
primary hepatocyte nuclei contained more PGC-1α protein
than NC controls following LPS exposure (Fig. 8d). Importantly, treatment with SR-18292, a selective inhibitor of PGC1α transcriptional activity [28], reduced AOAH expression in
LPS-treated Hspa12ao/e primary hepatocytes (Fig. 8e).
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Discussion
The present study has revealed that HSPA12A directs LPS
inactivation to reduce susceptibility to pyroptosis of hepatocytes. This effect of HSPA12A is mediated through
inhibition of cytosolic LPS-induced pyroptosis via PGC-1αmediated AOAH expression in hepatocytes.
Among the superfamily of heat shock proteins, HSP70
and HSP90 are involved in liver injury during sepsis/septic
shock [29–31]. As examples, inhibition of HSP90 reduces
proinﬂammatory cytokine production and prevents LPSinduced liver injury [29], whereas induction of endogenous
HSP70 and HSP27 or treatment with exogenous HSP70
ameliorates the hepatic and cardiac lesions associated with
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the anti-inﬂammatory responses during experimental septic
shock [30–32]. In the present study, we found that
HSPA12A, a novel member of HSP70 family, translocates
to the nucleus of hepatocytes following LPS exposure,
suggesting its possible involvement in the hepatic injury
during sepsis. Indeed, we found that LPS-induced hepatic
injury was exacerbated by HSPA12A deﬁciency in mice.
Moreover, the primary hepatocyte injury induced by LPS
was exacerbated by HSPA12A deﬁciency but attenuated by
HSPA12A overexpression. We also found lower body
temperature and activity in HSAP12A knockout mice than
WT controls after LPS challenge. Taken together, these
results provide clear evidence that HSPA12A protects the
liver from LPS-induced injury.
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Fig. 8 HSPA12A upregulated AOAH expression through interaction with PGC-1α in hepatocytes. a HSPA12A increased nuclear
contents of PPARγ and C/EBPα in LPS-treated hepatocytes. WT
primary hepatocytes were infected with Hspa12a-adenovitus to overexpress HSPA12A (Hspa12ao/e). WT hepatocytes infected with empty
virus served as negative controls (NC). After incubation with LPS for
6 h, the nuclear fractions were prepared for immunoblotting with the
indicated antibodies. Data are mean ± SD, **P < 0.01 by Student’s
two-tailed unpaired t test. n = 5 for PPARγ group, n = 6 for C/EBPα
group. b Interaction between HSPA12A and PGC-1α in hepatocytes.
Primary WT hepatocytes that overexpressing the ﬂag-tagged
HSPA12A (Hspa12ao/e) were incubated with LPS for 6 h. Primary
hepatocytes infected empty virus served as negative controls (NC).
Cellular protein extracts were immunoprecipitated with primary antibody for ﬂag. The immunoprecipitates were blotted with the indicated
antibodies. Protein extracts without immunoprecipitation (input)
served as positive controls, and immunoprecipitates from IgG incubation served as negative controls. Note that only PGC-1α was
recovered in ﬂag-tagged HSPA12A immunoprecipitates. c Nuclear
PGC-1α content was increased by HSPA12A overexpression but
decreased by HSPA12A deﬁciency. Hspa12ao/e primary hepatocytes
and its NC controls, Hspa12a−/− primary hepatocytes and its WT
controls were treated with LPS for 6 h. Nuclear fractions were prepared for immunoblotting against PGC-1α and HSPA12A. Data are
mean ± SD, **P < 0.01 by Student’s two-tailed unpaired t test. n = 6/
group for left panels and n = 3/group for right panels. d HSPA12A
increased nuclear PGC-1α abundance in LPS-treated hepatocytes.
Hspa12ao/e and NC primary hepatocytes were treated with LPS for 6 h.
PGC-1α in nuclei was examined by immunostaining. Hoechst 33342
was used to counter staining nuclei. Data were expressed as ﬂuorescence intensity/nucleus. Scale bar = 20 μm. Data are mean ± SD, **P
< 0.01 by Student’s two-tailed unpaired t test. n = 3/group. e Inhibition
of PGC-1α decreased AOAH expression in Hspa12ao/e hepatocytes.
Hspa12ao/e primary hepatocytes were treated with PGC-1α inhibitor
SR-18292 or vehicle for 12 h followed by incubation with LPS for 6 h.
AOAH expression was examined by immunoblotting. Data are mean
± SD, **P < 0.01 by Student’s two-tailed unpaired t test. n = 5/group.
f Mechanism scheme. By directly binding to PGC-1α, HSPA12A
promotes PGC-1α translocation to nuclei, thereby promotes AOAH
expression for LPS inactivation, and ultimately leads to hepatic protection through inhibition of Caspaase11-mediated pyroptosis of
hepatocyte.

LPS enters the circulation in large quantities following
Gram-negative bacterial infection and is a pathogenassociated molecular pattern. This circulating LPS activates canonical mammalian host-cell detection mechanisms by binding to cell-surface TLR4. However, recent
studies conducted in macrophages and endothelial cells
have shown that another intracellular/cytosolic LPSsensing pathway may be more important for the development of sepsis/septic shock [4, 5]. Intracellular LPS,
which is generated by Gram-negative bacteria within cells
or imported by a mechanism involving lipoproteins and
high mobility group box 1 [8, 33], is sensed by proinﬂammatory Caspase-4 and -5 in humans or their ortholog
Caspase-11 in rodents and leading to the generation of
GSDMDNterm, which induces pyroptosis by forming
membrane pores and increasing the secretion of proinﬂammatory mediators [8]. Pyroptosis is a form of
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programmed lytic cell death that is induced by proinﬂammatory Caspases, but little is known about its role in
hepatocyte death and acute liver injury. In the present
study, we have made three key ﬁndings. First, intracellular LPS was present in both hepatocytes of livers of
LPS-treated mice and in primary hepatocyte cultures
incubated with LPS. Second, LPS induced pyroptosis in
both mouse livers and primary hepatocyte cultures, as
demonstrated by Caspase-11 activation and GSDMDNterm
generation (markers of pyroptosis). Third, intracellular
LPS accumulation and Caspase-11-mediated hepatocyte
pyroptosis were promoted by HSPA12A deﬁciency but
attenuated by HSPA12A overexpression. These ﬁndings
imply that LPS can enter hepatocytes and activate
Caspase-11-mediated pyroptosis, and that this is inhibited
by HSPA12A overexpression.
Evidence has shown that Gram-negative enteropathogens activate TLR4-TRAM for type I interferon induction
through the interferon regulatory factors IRF3/7, while
Type I interferon can stimulate Caspase-11 and leading to
inﬂammatory tissue damage during endotoxic shock
[9, 34]. However, the sensing of intracellular LPS by
Caspase-4/5/11 is critical for the activation of pyroptosis.
This raises the possibility that the inactivation of intracellular LPS could be protective against the LPS-induced
cell damage. Indeed, previous studies have demonstrated
that LPS can be cleared effectively by hepatocytes and
Kupffer cells followed by excretion via the bile canalicular system [35, 36]. Recent studies have shown that
intracellular LPS can be biologically inactivated by
AOAH, which results in a desensitization of LPS by
Caspase-4/5/11 [10, 21]. AOAH is expressed in various
phagocytes, including Kupffer cells and hepatic dendritic
cells; however, it was unknown whether AOAH is
expressed in hepatocytes. In the present study, we have
shown that AOAH was expressed in hepatocytes and was
upregulated in response to LPS exposure. Moreover,
HSPA12A overexpression increased, but HSPA12A
deﬁciency reduced, AOAH expression in hepatocytes.
Importantly, overexpression AOAH prevented the
HSPA12A deﬁciency-induced promotion of the LPSinduced, Caspase-11-mediated pyroptosis of hepatocytes.
When taken into account that Hspa12a−/− mice exhibited
exacerbated liver injury, lower body temperature and less
activities, our ﬁndings suggest that HSPA12A protects
liver and improves systemic conditions from LPS challenge via an AOAH-dependent mechanism.
To further explore the mechanism whereby HSPA12A
upregulates AOAH expression, we aimed to identify the
transcription factors responsible for regulating AOAH
gene expression. Gene promoter analysis (http://generegulation.com) demonstrated putative binding sites
for C/EBPα and PPARγ within the Aoah promoter.
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Considering this ﬁnding alongside the fact that HSPA12A
translocated to the nucleus following LPS challenge, we
hypothesized that HSPA12A may bind and promote the
nuclear translocation of these transcription factors,
resulting in transcription of Aoah gene. However,
although we identiﬁed an effect of HSPA12A on the
nuclear translocation of C/EBPα and PPARγ in hepatocytes, no direct interaction of HSPA12A with C/EBPα or
PPARγ was detected using immunoprecipitation- immunoblotting analysis. However, this analysis did reveal that
HSPA12A forms a complex with PGC-1α in hepatocytes,
and that HSPA12A overexpression increased the nuclear
abundance of PGC-1α. Furthermore, inhibition of the
transcriptional activity of PGC-1α using SR-18292 [28]
prevents HSPA12A-induced AOAH expression in hepatocytes. Collectively, these results indicate that HSPA12A
interacts with PGC-1α and increases its nuclear translocation, thereby inducing AOAH expression for cytosolic
LPS inactivation, which ultimately leading to inhibition of
the Caspase-11-mediated pyroptosis of hepatocytes that
manifested reduced liver injury and improved systemic
conditions during endotoxemia (Fig. 8f).
In conclusion, we have shown that HSPA12A protects
mouse livers from the LPS-induced experimental sepsis.
This action of HSPA12A is achieved through inhibition of
intracellular LPS-induced pyroptosis, which is dependent
on PGC-1α-mediated AOAH expression. These ﬁndings
suggest that hepatocyte HSPA12A represents a viable
target for the management of liver injury in sepsis
patients.
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Animals
Conditional Hspa12a knockout mice were generated using
the loxP and Cre recombinant system as described in our
previous studies [16, 17]. The mice were bred at the Model
Animal Research Center of Nanjing University and were
maintained in the Animal Laboratory Resource Facility of the
same institution. All experiments conformed to the Guide for
the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication, 8th Edition,
2011). The animal care and experimental protocols were
approved by Nanjing University’s Committee on Animal
Care. All experiments conformed to international guidelines
on the ethical use of animals.
Mice (C57BL/6 background) were randomly assigned to
all analyses. Investigators were blinded to the histological
analysis. Investigators involved in animal handling, sampling, and raw data collection were not blinded.

LPS treatment
An LPS-induced experimental sepsis model was established
by injection male mice (8–10 weeks of age) intraperitoneally with LPS or FITC-LPS at a dosage of 5 mg/kg
body weight. NS-treated mice served as controls. Food and
water were provided ad libitum. Six hours after LPS treatment, blood was sampled and tissues were collected for the
indicated measurements.
In primary hepatocyte experiments, cells were incubated
with LPS or FITC-LPS (500 ng/ml) for 6 h. Saline-treated
primary hepatocytes served as controls. Culture medium
and cells were collected for the indicated analysises.

Materials and methods
Reagents

Immunoblotting and immunoprecipitationimmunoblotting

Escherichia coli LPS (0111:B4), FITC-conjugated LPS
from E. coli 0111:B4 (FITC-LPS) and paraformaldehyde
(PFA) was from Sigma-Aldrich (St. Louis, MO). Collagenase Type 4 was from Worthington biochemical
Corporation (Lakewood, NJ). Percoll density gradient
media was from GE Healthcare (Uppsala, Sweden).
Normal goat serum was from Jackson ImmunoResearch
(West Grove, PA). Trizol reagent was from Life Technology (Carlsbad, CA). SYBR Green Master and bovine
serum albumin (BSA) was from Roche (Basel, Switzerland). DMEM medium and fetal bovine serum (FBS) was
from Gibco (Shelton, CT). High-sig ECL western blotting
substrate was from Tanon (Shanghai, China). Protein AAgarose was from Santa Cruz Biotechnology (Dallas,
TX). Lactic acid dehydrogenase (LDH) assay kit was from
Jiancheng Biotech (Nanjing, China).

Cytosolic and pellet fractions were prepared from livers or
cells. Western blotting was performed according to our
previous methods [16, 17]. To control for lane loading, the
membranes were probed with anti-GAPDH antibody for
cytosolic proteins and anti-Lamin A/C antibody for pellet
proteins.
For analyzing interaction between HSPA12A and other
proteins by immunoprecipitation- immunoblotting, WT
primary hepatocytes were overexpressed with ﬂag-tagged
HSPA12A. After challenged with LPS for 6 h, cells were
collected for protein extraction. Aliquots of equal volume
and protein content were precipitated with anti-ﬂag antibodies, followed by Western blotting for C/EBPα, PPARγ,
PGC-1α and HSPA12A as described previously [17, 37].
The primary antibodies used in the experiments are listed
in Supplementary Table S1.
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Evaluation of LPS abundance within hepatocytes

Adenovirus construction

In mouse experiments, serum and tissues of livers were
collected 6 h after FITC-LPS treatment. The LPS abundance in serum and liver homogenates was indicated
by FITC ﬂuorescence intensity using a ﬂuorometer
(Synergy HT, BIO-TEK, USA) at excitation /emission
wavelengths of 490/530 nm. For visualizing the FITCLPS in hepatocytes, the frozen sections of PFA-ﬁxed liver
tissues were immunostained with alpha-fetoprotein
(AFP). Hoechst33342 was used to counter stain nuclei.
In primary hepatocyte experiments, cells were ﬁxed with
PFA after incubation with FITC-LPS for 6 h. The ﬁxed cells
were counter stained with Hoechst33342 to visualize nuclei.
The staining was observed using a ﬂuorescence microscope
and quantiﬁed using Cellsens Dimention 1.15 software
(Olympus, Tokyo, Japan).

The adenoviral vector containing a three ﬂags-tagged
coding region of mouse Hspa12a (NM_175199) was
generated by GeneChem (Shanghai, China) as described
in our previous studies [16, 17]. The adenoviral vector
containing a three ﬂags-tagged coding region of mouse
Aoah (NM_012054) was generated by GeneChem
(Shanghai, China). A schematic overview of Aoah virus
construction is shown in Supplementary Fig. S4.

Quantitative real-time PCR
Quantitative real-time PCR was performed as described
previously [16, 17]. Brieﬂy, Total RNA was isolated for
cDNA synthesis. The expressions of indicated genes were
estimated by real-time PCR using the SYBR Green Master.
The PCR results of Actin served as internal controls. The
primers used for PCR are listed in Supplementary
Table S2.

Biochemical analysis
Activities of aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) in mouse serum and cell culture
medium were measured using a Beckman Coulter AU5800
Chemistry System analyzer (Brea, CA).

Histological analysis and immunoﬂuorescence
staining
Parafﬁn-embedded liver sections were stained with H&E
to evaluate the inﬂammation foci formation. Immunoﬂuorescence staining on frozen liver sections or primary
hepatocytes was performed as described previously using
appropriate antibodies [16, 17] (Supplementary Table S1).
Brieﬂy, after incubation with the indicated primary
antibodies (1:100) overnight at 4 °C, Cy3- or FITCconjugated appropriate secondary antibodies were added
to the sections to visualize the staining. Hoechst 33342
reagent was used to counterstain the nuclei. The staining
was observed and quantiﬁed in ten randomly selected ten
areas of each sample using a ﬂuorescence microscope
with Cellsens Dimention 1.15 software (Olympus, Tokyo,
Japan).

Primary hepatocyte isolation and culture
Primary hepatocytes were isolated and grown according to
our previous methods [17]. Brieﬂy, hepatocytes were isolated
from 7–10-week-old mice by digestion with 0.06% collagenase type IV, followed by centrifugation on a 25–50%
Percoll gradient. Primary hepatocytes were grown in DMEM
supplemented with 10% FBS and 0.01 mM dexamethasone.
To overexpress HSPA12A (Hspa12ao/e) or AOAH
(Aoaho/e), primary hepatocytes were infected with adenovirus carrying the expression sequence of Hspa12a or Aoah
for 48 h. Cells infected with empty adenovirus served as
normal expression controls (NC).
To knockdown of AOAH or Caspase-11 expression,
primary hepatocytes were transfected with siRNA that targeting mouse Aoah mRNA (Si-Aoah) or Caspase-11
mRNA for 48 h, respectively. The primary hepatocytes
transfected with Scramble RNA served as controls
(Scramble). The siRNA sequences were shown in Supplementary Table S3.

Statistical analysis
Data are expressed as the mean ± standard deviation.
Groups were compared using Student’s two-tailed unpaired
t test, or using two-way ANOVA followed by Tukey’s posthoc test. A P value of < 0.05 was considered signiﬁcant.
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